International Journal of Internal Medicine

Objective To analyze the effect of insulin aspart in the treatment of gestational diabetes. Methods The study time was from September 2020 to August 2022. The study subjects were 70 patients with gestational diabetes admitted to our hospital. The grouping method was randomized. The control group was given routine nursing care, and the observation group was treated with aspartic insulin to compare the effect of blood glucose control and pregnancy outcome. Results The blood glucose control level in the observation group was lower than that in the control group after treatment (P<0.05); The blood glucose control time of the observation group was earlier than that of the control group, the amount of insulin was less, and the incidence of hypoglycemia was lower (P<0.05); The proportion of adverse pregnancy outcome in the observation group was lower than that in the control group (P<0.05); There was no adverse reaction in the observation group, and only one case of urinary tract infection occurred in the control group. Conclusion The application of insulin aspart has a good effect on the blood sugar control of pregnant diabetes patients. The blood sugar control time is early, the amount of insulin is small, and the adverse reaction of hypoglycemia can be reduced. With the application of aspartic insulin, the patient achieved a better pregnancy outcome, and the safety of medication was fully guaranteed.

Gestational diabetes; Aspartate insulin; Blood glucose; pregnancy outcome